Interleukin-11 (oprelvekin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-11 (oprelvekin), covering 2016-03-02 to 2016-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of IL-11 in DDAVP Unresponsive [Phase 2]